Botanix Pharma Overview
- Founded
- 2015

- Status
- Public
- Employees
- 1

- Stock Symbol
- BOT

- Share Price
- $0.08
- (As of Friday Closing)
Botanix Pharma General Information
Description
Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.
Contact Information
- PO Box 1407
- Subiaco, Western Australia 6904
- Australia
Botanix Pharma Timeline
Botanix Pharma Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.08 | $0.09 | $0.01 - $0.14 | $78.8M | 973M | 5.09M |
Botanix Pharma Financials Summary
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
---|---|---|---|---|
EV | 78,991 | 9,421 | 85,950 | 42,134 |
Revenue | 7 | |||
EBITDA | (6,218) | (11,225) | (12,264) | (8,596) |
Net Income | (6,239) | (11,207) | (12,183) | (8,530) |
Total Assets | 20,560 | 17,392 | 3,642 | 13,010 |
Total Debt | 243 | 289 | 0 | 0 |
Botanix Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Botanix Pharma‘s full profile, request access.
Request a free trialBotanix Pharma Executive Team (6)
Botanix Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial